REGISTRATION OBTAINED FOR AIRING™ IN CROATIA, BULGARIA, AND ROMANIA

In the last quarter of 2023 marketing authorizations were obtained in Croatia, Romania, Bulgaria for Airing™. Airing™ has been licensed from Mithra (Belgium) and is a generic version of Nuvaring™, a hormonal contraceptive vaginal ring. Market introductions are expected in the first and second half of 2024.

About Airing™

Airing™ (etonogestrel/ethinyl estradiol vaginal ring) is a non-biodegradable, flexible, transparent, combination contraceptive vaginal ring, with an outer diameter of 54 mm and a cross-sectional diameter of 4 mm. It is made of ethylene vinylacetate copolymers, and contains 11.7 mg etonogestrel and 2.7 mg ethinyl estradiol. When placed in the vagina, each ring releases, in line with the originator (Nuvaring®), on average 0.120 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol over a three-week period of use. The ring is to remain in place continuously for three weeks. It is removed for a one-week break, during which a withdrawal bleed usually occurs. A new ring is inserted one week after the last ring was removed. In comparison to oral contraceptives patient compliance increases and side effects are less.